
Loading, please wait...

Loading, please wait...

Amato and colleagues analysed individual patient data from several ARDS trials to explore which mechanical-ventilation variables were most strongly associated with survival. Across the combined dataset, driving pressure—the difference between plateau pressure and PEEP—showed the strongest association with mortality among the variables examined. The analysis suggested that the amount of pressure actually distending the respiratory system during tidal inflation may capture the functional “size” of the remaining aerated lung better than tidal volume or plateau pressure considered alone. This was not a randomised trial of a driving-pressure-targeted treatment strategy, so the findings do not prove that lowering driving pressure itself will improve outcomes. Nevertheless, the work provided an important physiologic framework for modern ventilator management. In clinical practice, it encourages clinicians to look beyond a single tidal-volume prescription and ask how much mechanical stress is being imposed on the available lung. Driving pressure can be influenced by tidal volume, respiratory system compliance and PEEP, making it useful as an integrated bedside signal. The paper helped accelerate a more personalised approach to ventilation in ARDS, in which airway pressures and respiratory mechanics are interpreted together rather than treated as isolated numbers.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Amato and colleagues analysed individual patient data from several ARDS trials to explore which mechanical-ventilation variables were most strongly associated with survival. Across the combined dataset, driving pressure—the difference between plateau pressure and PEEP—showed the strongest association with mortality among the variables examined. The analysis suggested that the amount of pressure actually distending the respiratory system during tidal inflation may capture the functional “size” of the remaining aerated lung better than tidal volume or plateau pressure considered alone. This was not a randomised trial of a driving-pressure-targeted treatment strategy, so the findings do not prove that lowering driving pressure itself will improve outcomes. Nevertheless, the work provided an important physiologic framework for modern ventilator management. In clinical practice, it encourages clinicians to look beyond a single tidal-volume prescription and ask how much mechanical stress is being imposed on the available lung. Driving pressure can be influenced by tidal volume, respiratory system compliance and PEEP, making it useful as an integrated bedside signal. The paper helped accelerate a more personalised approach to ventilation in ARDS, in which airway pressures and respiratory mechanics are interpreted together rather than treated as isolated numbers.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back